GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » CTT Pharmaceutical Holdings Inc (OTCPK:CTTH) » Definitions » Cash Ratio

CTT Pharmaceutical Holdings (CTT Pharmaceutical Holdings) Cash Ratio : 3.40 (As of Jun. 2018)


View and export this data going back to . Start your Free Trial

What is CTT Pharmaceutical Holdings Cash Ratio?

The Cash Ratio measures a company’s ability to meet its short-term obligations with cash and near-cash resources. It is calculated as a company's Cash, Cash Equivalents, Marketable Securities divides by its Total Current Liabilities. CTT Pharmaceutical Holdings's Cash Ratio for the quarter that ended in Jun. 2018 was 3.40.

CTT Pharmaceutical Holdings has a Cash Ratio of 3.40. It generally indicates that the company is able to cover all short-term debt and still have cash remaining.

The historical rank and industry rank for CTT Pharmaceutical Holdings's Cash Ratio or its related term are showing as below:

CTTH's Cash Ratio is not ranked *
in the Drug Manufacturers industry.
Industry Median: 0.59
* Ranked among companies with meaningful Cash Ratio only.

CTT Pharmaceutical Holdings Cash Ratio Historical Data

The historical data trend for CTT Pharmaceutical Holdings's Cash Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CTT Pharmaceutical Holdings Cash Ratio Chart

CTT Pharmaceutical Holdings Annual Data
Trend Dec06 Dec07 Dec08 Dec09 Dec10 Dec11 Dec12 Dec13 Dec14 Dec15
Cash Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.15 0.30 - 0.48 -

CTT Pharmaceutical Holdings Quarterly Data
Dec12 Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Mar17 Jun17 Mar18 Jun18
Cash Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.03 - - 0.37 3.40

Competitive Comparison of CTT Pharmaceutical Holdings's Cash Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, CTT Pharmaceutical Holdings's Cash Ratio, along with its competitors' market caps and Cash Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


CTT Pharmaceutical Holdings's Cash Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, CTT Pharmaceutical Holdings's Cash Ratio distribution charts can be found below:

* The bar in red indicates where CTT Pharmaceutical Holdings's Cash Ratio falls into.



CTT Pharmaceutical Holdings Cash Ratio Calculation

The Cash Ratio measures a company's ability to meet its short-term obligations with its cash and near-cash resources.

CTT Pharmaceutical Holdings's Cash Ratio for the fiscal year that ended in Dec. 2015 is calculated as:

Cash Ratio (A: Dec. 2015 )=Cash, Cash Equivalents, Marketable Securities/Total Current Liabilities
=0.001/0.308
=0.00

CTT Pharmaceutical Holdings's Cash Ratio for the quarter that ended in Jun. 2018 is calculated as:

Cash Ratio (Q: Jun. 2018 )=Cash, Cash Equivalents, Marketable Securities/Total Current Liabilities
=0.996/0.293
=3.40

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


CTT Pharmaceutical Holdings  (OTCPK:CTTH) Cash Ratio Explanation

The cash ratio is more conservative than other liquidity ratios, such as Quick Ratio and Current Ratio, because it only considers a company's most liquid resources. The numerator of cash ratio only considers Cash, Cash Equivalents and marketable securities. Other current assets, such as accounts receivable and inventories, are not included. The rationale is that these assets may require time to be transformed into cash, and the amount of money received is also uncertain.

The cash ratio shows a company’s ability to pay all current liabilities immediately without selling or liquidating other assets. Generally speaking, a higher cash ratio suggests the company has a stronger ability to cover its short-term debt. However, a high cash ratio could also indicate inefficient management: the company is inefficient in making full utilization of cash to invest protential profitable project. It may also suggest that the company is not confident about future profitability.

In general, the higher the cash ratio, the better the company's liquidity position.


CTT Pharmaceutical Holdings Cash Ratio Related Terms

Thank you for viewing the detailed overview of CTT Pharmaceutical Holdings's Cash Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


CTT Pharmaceutical Holdings (CTT Pharmaceutical Holdings) Business Description

Traded in Other Exchanges
N/A
Address
1100 – 1111 Melville Street, Vancouver, BC, CAN, V6E 3V6
CTT Pharmaceutical Holdings Inc is a development stage company specializing in drug delivery systems technology within the pharmaceutical industry. It focuses on fast-dissolving drug delivery systems through the development of oral delivery thin wafers. The thin wafers are infused with both natural and synthetic cannabis extracts to deliver treatment as an alternative to smoking and ingestion. Its products include Medwafe, Cannawafe, Vetwafe, and others.
Executives
Albert C Zapanta director PO BOX 2020, SPRINGDALE AR 72765
William Thomson director 390 BAY ST, SUITE 1102, TORONTO ONTARIO A6 M5H 2Y2